Form 8-K - Current report:
SEC Accession No. 0001193125-25-067174
Filing Date
2025-03-28
Accepted
2025-03-28 16:37:27
Documents
14
Period of Report
2025-03-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d910168d8k.htm   iXBRL 8-K 23345
2 EX-99.1 d910168dex991.htm EX-99.1 14300
  Complete submission text file 0001193125-25-067174.txt   162301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blue-20250328.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20250328_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20250328_pre.xml EX-101.PRE 10821
16 EXTRACTED XBRL INSTANCE DOCUMENT d910168d8k_htm.xml XML 3503
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 25786999
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)